Skip to content
Springfield Meetings

Planning & Zoning Commission, March 12, 2026

Approves Rezoning PD 395 at 3302 South Maryland Avenue, Passed (specific count not stated)

2h 36m22,192 words
137 mentionszoningpublic hearingmotion to approverezoneplanned developmentresidentialcomprehensive plandensitytraffic studyapprovedsetbackrezoningvarianceduplexshort term rentaldeniedcommercialmixed useannexationsubdivisiondeferredland useSpringfield, MO
Just researching this meeting? Get free Springfield alerts

What happened

The Planning & Zoning Commission approved PD 395, a 198-unit, four-story multifamily development at 3302 South Maryland Avenue on 7.64 acres, despite neighborhood opposition citing traffic concerns.

Meeting key facts
Jurisdiction
Springfield, MO
Governing body
Final authority
Date
March 12, 2026
Decisions
6 zoning decisions
Outcome
Approved, Passed (specific count not stated)

Projects in this meeting (2)

Kearney Street Corridor Redevelopment Plan - First Amended and Restate

Recommended
1 condition of approval

Land Development Code Text

Awaiting final vote
1 condition of approval

Free sample: decision 1 of 6

Rezoning PD 395 at 3302 South Maryland Avenue

Approved rezoning of 7.64 acres from PD 13 third amendment and RSF to new PD 395 for a 198-unit, four-story multifamily development called 'The Reserve on Medical Mile.' Density increased from 16 to 29 dwelling units per acre. Maximum height increased from 35 feet to 60 feet. Developer Nathan Reynolds and architect Brian Kubik presented. Vote passed with some opposition from commissioners Hawquez and Pauley who cited traffic concerns.

  • Traffic study required at time of development; Type E buffer retained; new 6-foot solid wood fence required along west property line; 45-degree bulk plane from east right-of-way line of Maryland Avenue; landscaping must meet current land development code requirements

The other decisions are listed below by title. The full write-up, verbatim conditions, and the audio at each vote are in Pro.

Meeting Summary

The Planning & Zoning Commission approved PD 395, a 198-unit, four-story multifamily development at 3302 South Maryland Avenue on 7.64 acres, despite neighborhood opposition citing traffic concerns.

Get email alerts for new Springfield meetings

Key Decisions (6)

Approved

Rezoning PD 395 at 3302 South Maryland Avenue

Vote: Passed (specific count not stated)Conditions attached
Denied

Short-term rental type two appeal at 1350 North Washington Avenue

Vote: Motion to approve failed (specific count not stated)
Approved

Land Development Code Text Amendment 2

Vote: Passed with one abstention (Commissioner Gunther)Conditions attached
Approved

Kearney Street Corridor Redevelopment Plan - First Amended and Restated

Vote: Passed with one abstention (Commissioner Gunther)Conditions attached
Tabled

Marijuana and medical marijuana uses hours of operation amendment

Vote: Passed (specific count not stated)
Approved

Rules of Procedure Amendment for Speaker Time

Vote: Passed (specific count not stated)

Zoning Changes (1)

7.64 acres

Development Activity (1)

The Reserve on Medical Mile

Residential

Market Signals (4)

Housing Demand

Developer cited strong demand for housing near major medical employers,…

Commercial Demand

Kearney Street Corridor redevelopment plan renewal indicates continued city focus…

Sentiment

Strong neighborhood opposition to short-term rentals in historic Midtown district,…

Infrastructure

Traffic concerns raised regarding roundabout capacity at Walnut Lawn and…

Meeting Intelligence Preview

Ask this meeting anything

Ask who voted, what conditions passed, and what staff recommended for "Planning & Zoning Commission - 2026-03-12", with every answer cited to the transcript. Included with Pro.

Learn about Meeting Q&A

Get every Springfield meeting with full decisions, votes, and zoning details, within hours of each session.

Just want to know when new Springfield meetings are posted? Get free email alerts below.

Follow Springfield

Get the agenda when a meeting is posted, plus decision and analysis alerts.

We'll email you an activation link — one click, no password, unsubscribe anytime.

or